SURVIVAL DISCRIMINANTS FOR DIFFERENTIATED THYROID-CANCER

被引:131
|
作者
CUNNINGHAM, MP [1 ]
DUDA, RB [1 ]
RECANT, W [1 ]
CHMIEL, JS [1 ]
SYLVESTER, J [1 ]
FREMGEN, A [1 ]
机构
[1] AMER CANC SOC,COMM CANC INCIDENCE & END RESULTS,CHICAGO,IL
来源
AMERICAN JOURNAL OF SURGERY | 1990年 / 160卷 / 04期
关键词
D O I
10.1016/S0002-9610(05)80539-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Since 1975, the American Cancer Society, Illinois Division, has published end results of major cancer sites drawn from patient data contributed voluntarily by hospital cancer registries throughout the state. The current study was undertaken, in part, to apprehend information regarding contested areas in the management of patients having differentiated (papillary/follicular) thyroid cancer. A total of 2,282 patients with either papillary or follicular carcinoma of the thyroid from 76 different Illinois hospitals and providing 10 years of follow-up information (life-table analysis) were retrospectively analyzed for demographic, disease, and treatment-related predictors of survival. Multivariate analysis using the Cox proportional hazards method was made for stage, age, race, sex, morphology, history of radiation exposure, presence of positive lymph nodes, initial surgical treatment, postoperative iodine 131 therapy, and replacement/ suppressive thyroid hormone treatment. Statistically significant (p≤0.05) predictors of favorable survival after thyroid cancer were low stage (I and II), young age (less than 50 years), white race, female sex, and the administration, postoperatively, of either thyroid hormone or radioactive iodine. Factors that had no influence on survival were lymph node status, choice of initial surgical treatment, and a history of prior irradiation. We suggest that where a prospective clinical trial is impracticable, a retrospective analysis of a large and detailed database, such as that available from cooperating hospital-based tumor registries, may yet provide useful insights to solutions of cancer management problems. © 1990 Reed Publishing USA.
引用
收藏
页码:344 / 347
页数:4
相关论文
共 50 条
  • [1] DIAGNOSTIC DISCRIMINANTS OF THYROID-CANCER
    EVANS, DM
    AMERICAN JOURNAL OF SURGERY, 1987, 153 (06): : 569 - 570
  • [2] DIFFERENTIATED THYROID-CANCER IN CHILDREN
    DEKEYSER, LFM
    VANHERLE, AJ
    HEAD & NECK SURGERY, 1985, 8 (02): : 100 - 114
  • [3] INFLUENCE OF CELLULAR DNA CONTENT ON SURVIVAL IN DIFFERENTIATED THYROID-CANCER
    JOENSUU, H
    KLEMI, P
    EEROLA, E
    TUOMINEN, J
    CANCER, 1986, 58 (11) : 2462 - 2467
  • [4] THYROID-HORMONES IN DIFFERENTIATED THYROID-CANCER
    SAMUEL, AM
    MEHTA, MN
    DESAI, KB
    CLINICAL NUCLEAR MEDICINE, 1994, 19 (01) : 49 - 53
  • [5] EXTERNAL RADIOTHERAPY OF DIFFERENTIATED THYROID-CANCER
    SCHEUMANN, GFW
    DRALLE, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (41) : 1576 - 1577
  • [6] SURGICAL REINTERVENTION FOR DIFFERENTIATED THYROID-CANCER
    GORETZKI, PE
    SIMON, D
    FRILLING, A
    WITTE, J
    REINERS, C
    GRUSSENDORF, M
    HORSTER, FA
    ROHER, HD
    BRITISH JOURNAL OF SURGERY, 1993, 80 (08) : 1009 - 1012
  • [7] DIFFERENTIATED THYROID-CANCER ON THE THYROGLOSSAL DUCT
    BOILEVE, JB
    MARTINEZ, HP
    DIZ, AE
    BLANCO, MCC
    RIVERA, MF
    GIL, PG
    JOURNAL DE CHIRURGIE, 1991, 128 (10): : 441 - 445
  • [8] SERUM THYROGLOBULIN IN DIFFERENTIATED THYROID-CANCER
    HAY, ID
    GORMAN, CA
    BRITISH MEDICAL JOURNAL, 1979, 2 (6197): : 1076 - 1076
  • [9] SURGERY OF METASTASES IN DIFFERENTIATED THYROID-CANCER
    ROHER, HD
    GORETZKI, PE
    WAHL, RA
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1987, 371 (02): : 103 - 113